Smpl Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-11-2024
- Paid Up Capital ₹ 3.00 M
as on 16-11-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 60.24 Cr
as on 16-11-2024
- Satisfied Charges ₹ 9.50 Cr
as on 16-11-2024
- Revenue 25.09%
(FY 2023)
- Profit -70.06%
(FY 2023)
- Ebitda -152.36%
(FY 2023)
- Net Worth 6.12%
(FY 2023)
- Total Assets 22.82%
(FY 2023)
About Smpl Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹60.24 Cr. The company has closed loans amounting to ₹9.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Sabharwal, Meenu Sabharwal, and Sarika Sabharwal serve as directors at the Company.
- CIN/LLPIN
U24232DL2011PTC229383
- Company No.
229383
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Smpl Life Sciences Private Limited offer?
Smpl Life Sciences Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Smpl Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Sabharwal  | Director | 28-Dec-2011 | Current |
| Meenu Sabharwal | Director | 28-Dec-2011 | Current |
| Sarika Sabharwal | Director | 28-Dec-2011 | Current |
Financial Performance of Smpl Life Sciences.
Smpl Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.09% increase. The company also saw a substantial fall in profitability, with a 70.06% decrease in profit. The company's net worth moved up by a moderate rise of 6.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Smpl Life Sciences?
In 2023, Smpl Life Sciences had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 06 Sep 2024 | ₹1.00 Cr | Open |
Others Creation Date: 08 Apr 2024 | ₹3.00 Cr | Open |
Others Creation Date: 07 Mar 2023 | ₹4.00 Cr | Open |
How Many Employees Work at Smpl Life Sciences?
Smpl Life Sciences has a workforce of 30 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smpl Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smpl Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
